Tuesday, November 9, 2010

Hot Scenes Of Mera Naam Joker

One in four "suns" could have planets the size of Earth

A team of researchers at the University Clinic of Navarra and CIMA are studying the use of snuff as a vaccine against follicular lymphoma, a tumor of the system node. The vaccine is performed by entering the patient's tumor cells on the soles of snuff and thus produce a protein. This is given to the patient in order to activate the immune system and get to destroy tumor cells.
The study was performed to twenty patients enrolled in the Southwestern Medical Center at Dallas (USA) while developing the vaccine will take place in the CUN and CIMA.

In this way, through trial assessing the efficacy of the proteins obtained by the sole of snuff, to which are personalized vaccines, which used to cost nine months to produce and thus takes place in six weeks.

personalized vaccine is made with the patient's own cells that have a protein on the surface (immunoglobulin) and after a manipulation can be used as a vaccine. This vaccine would follicular lymphoma is a type of cancer that is characterized by the growth of B cells and is very common in Spain about 5,000 cases per year in adults over 40 years.

The trial has been given to the group of Maurizio Benandi by the results obtained in 2006 with the first personalized vaccines.

This information comes from the Diario de Navarra
Posted by admin at 12:31 PM

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)